What is Matrix Technologies?
Established in 1991 and headquartered in the San Francisco Bay Area, Matrix Technologies designs and validates manufacturing control systems using industry-standard Good Automated Manufacturing Practices (GAMP). Their highly structured approach ensures traceable validation of systems, leading to exceptional reliability in biotech manufacturing processes. The company prides itself on aligning with customer strategic visions, fostering enduring partnerships through expert engineering, accurate time and budget tracking, and detailed invoicing. Matrix Technologies also provides recruitment and training for control systems engineers, integrating them seamlessly into client teams to execute control qualification services and drive projects to completion. While their expertise spans food, energy, and pharmaceutical sectors, their primary focus and passion lie within the biotech industry, making them a premier control system integrator in a major biotech hub.
How much funding has Matrix Technologies raised?
Matrix Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Matrix Technologies
PPP
Public-Private Partnership
What's next for Matrix Technologies?
With a history of large-scale, late-stage funding and a recent major strategic investment, Matrix Technologies is poised to further solidify its leadership in biotech control system integration. The company's commitment to rigorous validation, client-centric partnerships, and specialized engineering talent suggests a trajectory focused on scaling operations, enhancing technological capabilities, and potentially expanding its service offerings to meet the evolving demands of the biopharmaceutical manufacturing sector. This strategic backing will likely fuel innovation in their GAMP-compliant solutions and reinforce their ability to manage complex projects for industry leaders.
See full Matrix Technologies company page
